Revance Therapeutics shares owned by Cannon Global Investment Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Cannon Global Investment Management
from 13F filings
Historical chart of Cannon Global Investment Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Cannon Global Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Cannon Global Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $142k | 27k | 5.19 |
More positions owned by Cannon Global Investment Management
View all positions for Cannon Global Investment Management